Both NHL and HD patients were then further evaluated for posttreatment changes in peripheral blood lymphocyte counts by flow cytometry and serum levels of vascular endothelial growth factor (VEGF), bFGF, and IFN‐γ by ELISA. This evidence concerns the gene VEGFA and Huntington disease.